Cost Curve

Does a New Analysis Comparing TrumpRx Prices to International Cash Prices Clarify Anything?

And a deep dive on 340B hospital financial assistance policies

Brian Reid

Keytruda, Opdivo Top a New Forecast of the 20 Drugs Due for Medicare ‘Negotiations’ Next Year

And Chris Klomp’s ducked MFN and TrumpRx questions from Senators; his nomination advances anyway

Brian Reid

Pfizer’s Bourla: CEOs Might Want to ‘Send Me Thank-You Notes’ for MFN Work

Brian Reid

One Big Beautiful Bridge: 700K Medicare Beneficiaries Have Opted Into CMS’ Obesity Pilot

And pressure on Europe -- especially Germany -- to raise drug prices intensifies

Brian Reid

Copies of Lilly and Pfizer’s MFN Deals Have Been Released. The Takeaway Is █ █ █ █ █ █ █ █ █ █ █ █ █ █

And South Dakota stopped a bounty program for racoon tails last year. That move saved more money than its new Medicaid MFN deal

Brian Reid

Two Reasons To View Today’s Medicaid Drug-Price News With Skepticism

Brian Reid

MFN Has Been Central to HHS Nominee Klomp’s Current Job at CMS, But Senators Entirely Ignore the Topic

And Census Bureau data shows that nonprofit hospital revenue surged 10% over the past year

Brian Reid

The Ten Questions I Wish Senators Had Asked HHS Deputy Nominee Chris Klomp

Brian Reid

Nineteen States Have Expressed Interest in CMS’ Effort to Bring MFN Prices to Medicaid, WaPo Says

And a spate of stories about how MFN might impact pricing and access overseas

Brian Reid